Science
Scientists use CRISPR-Cas9 to prevent Fuchs’ corneal dystrophy in mice – Medical Xpress
In a new study, researchers at the University of Oregon’s Phil and Penny Knight Campus for Accelerating Scientific Impact used…
In a new study, researchers at the University of Oregon’s Phil and Penny Knight Campus for Accelerating Scientific Impact used start codon disruption with CRISPR-Cas9 gene editing to prevent Fuchs’ corneal dystrophy in mice. It is the first demonstrated…
Continue Reading
-
Noosa News23 hours agoBrisbane at centre of Queensland’s illegal cigarette boom
-
Business22 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News24 hours agoWith The Horrors, Clown Core, a Car Crash and an Artist Inside an Hourglass on Its 2025 Lineup, Dark Mofo Is Definitely Back
-
Noosa News24 hours agoHow to Make the Most of Your Japan Trip During Cherry Blossom Season